Certain Common Stock of Guardant Health, Inc. are subject to a Lock-Up Agreement Ending on 22-JUL-2023.

Source: https://www.marketscreener.com/quote/stock/GUARDANT-HEALTH-INC-46434671/news/Guardant-Health-Provides-Update-on-COBRA-Study-Restates-Confidence-in-MRD-Test-44757491/?utm_medium=RSS&utm_content=20230901

Finally, Citigroup raised their target price on shares of Guardant Health from $40.00 to $50.00 and gave the stock a “buy” rating in a report on Friday, August 4th.

Source: https://www.etfdailynews.com/2023/08/29/guardant-health-inc-nasdaqgh-shares-bought-by-guggenheim-capital-llc/

Finally, Price T Rowe Associates Inc. MD grew its holdings in shares of Guardant Health by 1.5% during the 3rd quarter.

Source: https://www.etfdailynews.com/2023/05/13/guardant-health-inc-nasdaqgh-stock-holdings-lessened-by-shell-asset-management-co/

Manchester Capital Management LLC increased its holdings in shares of Guardant Health by 43.0% in the 3rd quarter.

Source: https://www.etfdailynews.com/2023/05/19/california-public-employees-retirement-system-lowers-holdings-in-guardant-health-inc-nasdaqgh/

Vanguard Group Inc. grew its holdings in shares of Guardant Health by 0.8% during the 3rd quarter.

Source: https://www.etfdailynews.com/2023/05/13/guardant-health-inc-nasdaqgh-stock-holdings-lessened-by-shell-asset-management-co/